NCCN Task Force Report: Oral chemotherapy, J Natl Compr Cancer Netw JNCCN. mars, vol.6, pp.1-14, 2008. ,
Oral Cancer Chemotherapy: The Critical Interplay Between Patient Education and Patient Safety, Current Oncology Reports, vol.334, issue.4, pp.247-252, 2010. ,
DOI : 10.1007/s11912-010-0103-6
Contribution of a preliminary socio-anthropological survey to the development of a therapeutic patient education programme for patients receiving oral chemotherapy. Educ Thérapeutique Patient -Ther Patient Educ, pp.101-107, 2010. ,
Adhésion thérapeutique aux traitements oncologiques oraux et prise en charge interdisciplinaire, Rev Med Suisse, vol.75, pp.1154-1160, 2011. ,
La décision thérapeutique personnalisée. Observance médicamenteuse, La revue du praticien, vol.55, 2005. ,
Medication Compliance and Persistence: Terminology and Definitions, Value in Health, vol.11, issue.1, pp.44-51, 2008. ,
DOI : 10.1111/j.1524-4733.2007.00213.x
Penser autrement l???observance m??dicamenteuse??: d???une posture injonctive ?? une alliance th??rapeutique entre le patient et le soignant ??? Concepts et d??terminants, Annales Pharmaceutiques Fran??aises, vol.70, issue.1, pp.15-25, 2012. ,
DOI : 10.1016/j.pharma.2011.10.003
Compliance, observance ou adhésion thérapeutique : de quoi parlons-nous ? Revue des maladies respiratoires, pp.31-34, 2005. ,
Comment ??valuer l???adh??sion m??dicamenteuse??? Le point sur les m??thodes, Annales Pharmaceutiques Fran??aises, vol.71, issue.2, pp.135-141, 2013. ,
DOI : 10.1016/j.pharma.2012.10.001
Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer, Annals of Oncology, vol.17, issue.2, pp.205-210, 2006. ,
DOI : 10.1093/annonc/mdj044
Adherence to Long-term Therapies: Evidence for Action, World Health, 2003. ,
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations, Value in Health, vol.10, issue.6, pp.498-509, 2007. ,
DOI : 10.1111/j.1524-4733.2007.00205.x
Making communication research matter: What do patients notice, what do patients want, and what do patients need?, Patient Education and Counseling, vol.60, issue.3, pp.272-278, 2006. ,
DOI : 10.1016/j.pec.2005.11.003
Learning needs of congestive heart failure patients, Prog Cardiovasc Nurs, vol.13, issue.2, pp.11-16, 1998. ,
Educational needs of inpatients with severe & persistent mental illness: a partial replication, J Psychosoc Nurs Ment Health Serv. mai, vol.44, issue.5, pp.38-43, 2006. ,
Quelles attentes des patients souffrant de cancers en hôpital de jour en termes d'information sur leur traitement ? Le Pharmacien Hospitalier et Clinicien, pp.183-190, 2010. ,
L'entretien -L'enquête et ses méthodes, Collection, vol.128, issue.19, 2005. ,
Méthodologie du recueil d'informations fondements des méthodes d'observation, de questionnaire, d'interview et d'étude de documents, 2009. ,
Les Techniques d'enquête : Méthode et exercices corrigés, 1998. ,
Health Psychology. McGraw-Hill International, 2012. ,
Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis, 2006. ,
Enhancing Patient Adherence to Improve Outcomes With Oral Chemotherapy, US Pharm, vol.32, issue.10, pp.1-8, 2007. ,
Capecitabine non-adherence: Exploration of magnitude, nature and contributing factors, Journal of Oncology Pharmacy Practice, vol.8, issue.1, pp.333-342, 2012. ,
DOI : 10.1080/08870449908407311
Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104, Journal of Clinical Oncology, vol.28, issue.14 ,
DOI : 10.1200/JCO.2009.26.4671
Patient noncompliance with self-administered chemotherapy, Cancer, vol.37, issue.1, pp.17-22, 1990. ,
DOI : 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I
Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study, Anticancer Res. avr, vol.31, issue.4, pp.1407-1409, 2011. ,
Prescription compliance and persistency in chronic myelogenous leukemia (CML) and gastrointestinal stromal tumor (GIST) patients (pts) on imatinib (IM), ASCO Annual Meeting Proceedings (Post- Meeting Edition, pp.2418-6119, 2006. ,
A review on adherence management in patients on oral cancer therapies, European Journal of Oncology Nursing, vol.16, issue.4, pp.432-438, 2012. ,
DOI : 10.1016/j.ejon.2011.10.002
Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents, Expert Opinion on Drug Safety, vol.10, issue.4, pp.49-59, 2012. ,
DOI : 10.1200/JOP.2010.000076
Évaluation de l'observance des thérapeutiques orales en oncologie : résultats d'une étude pilote, J Pharm Clin. 1 juin, vol.30, issue.2, pp.83-93, 2011. ,
What affects patient adherence to oral chemotherapy? ONS Connect, avr, vol.27, issue.4, p.24, 2012. ,
Patient adherence and persistence with oral anticancer treatment, CA: A Cancer Journal for Clinicians, vol.59, issue.1, pp.56-66, 2009. ,
DOI : 10.3322/caac.20004
Nonadherence in Patients With Breast Cancer Receiving Oral Therapies, Clinical Journal of Oncology Nursing, vol.14, issue.1, pp.41-47, 2010. ,
DOI : 10.1188/10.CJON.41-47
S??curisation de l???emploi des chimioth??rapies anticanc??reuses administrables par voie orale, Le Pharmacien Hospitalier, vol.44, issue.1, pp.36-44, 2009. ,
DOI : 10.1016/j.phhp.2008.12.002
Patient preferences for oral versus intravenous palliative chemotherapy., Journal of Clinical Oncology, vol.15, issue.1, pp.110-115, 1997. ,
DOI : 10.1200/JCO.1997.15.1.110
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin, European Journal of Cancer, vol.38, issue.3, pp.349-358, 1990. ,
DOI : 10.1016/S0959-8049(01)00371-9
Anticancer oral therapy: Emerging related issues, Cancer Treatment Reviews, vol.36, issue.8, pp.595-605, 2010. ,
DOI : 10.1016/j.ctrv.2010.04.005
A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer, Annals of Oncology, vol.17, issue.2, pp.239-245, 2006. ,
DOI : 10.1093/annonc/mdj023
Prerequisites to the administration and prevention of adverse effects of chemotherapy in colorectal cancer]. Bull Cancer (Paris), févr, vol.97, issue.2, pp.265-280, 2010. ,
Costs and utilization associated with imatinib adherence in patients with chronic myeloid leukemia or gastrointestinal stromal turmor, JCOM, vol.16, issue.5, p.215, 2009. ,
The impact of non-compliance with imatinib (IM) therapy on health care costs, ASCO Annual Meeting Proceedings (Post-Meeting Edition, pp.2418-6083, 2006. ,
Médecines complémentaires et alternatives suivies par les patients cancéreux en France, Bull Cancer, vol.94, issue.5, pp.483-488, 2007. ,
A study of quality of life in cancer patients receiving palliative chemotherapy, Social Science & Medicine, vol.35, issue.12, pp.1505-1509, 1992. ,
DOI : 10.1016/0277-9536(92)90053-S
Thérapies ciblées en oncologie digestive, Revue Med Suisse. 25 mai, vol.296, issue.20, pp.1131-1136, 2011. ,
Angiogenesis: Tumorigenesis and the angiogenic switch, Nature Reviews Cancer, vol.3, issue.6, pp.401-410, 2003. ,
DOI : 10.1038/nrc1093
The erbB Family: Targets for Therapeutic Development Against Cancer and Therapeutic Strategies Using Monoclonal Antibodies and Tyrosine Kinase Inhibitors, Annual Review of Medicine, vol.55, issue.1, pp.433-457, 2004. ,
DOI : 10.1146/annurev.med.55.091902.104433
HER receptor protein-tyrosine kinases and cancer Sunitinib versus interferon alfa in metastatic renal-cell carcinoma, Biochem Biophys Res Commun. 18 juin N Engl J Med. 11 janv, vol.319356, issue.12, pp.115-124, 2004. ,
Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma, New England Journal of Medicine, vol.356, issue.2, pp.125-134, 2007. ,
DOI : 10.1056/NEJMoa060655
Lapatinib plus Capecitabine for HER2-Positive Advanced Breast Cancer Capecitabine nonadherence: exploration of magnitude, nature and contributing factors, N Engl J Med. J Oncol Pharm Pr Off Publ Int Soc Oncol Pharm Pr. sept, vol.35518, issue.204, pp.5319-5339, 2006. ,
The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in Oncology, JNCI Journal of the National Cancer Institute, vol.85, issue.5, pp.365-376, 1993. ,
DOI : 10.1093/jnci/85.5.365
Assessing drinkers' motivation for change: The Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES)., Psychology of Addictive Behaviors, vol.10, issue.2, pp.81-89, 1996. ,
DOI : 10.1037/0893-164X.10.2.81
NCCN Task Force Report: Oral chemotherapy, J Natl Compr Cancer Netw JNCCN. mars, vol.6, pp.1-14, 2008. ,
Oral Cancer Chemotherapy: The Critical Interplay Between Patient Education and Patient Safety, Current Oncology Reports, vol.334, issue.4, pp.247-252, 2010. ,
DOI : 10.1007/s11912-010-0103-6
Contribution of a preliminary socio-anthropological survey to the development of a therapeutic patient education programme for patients receiving oral chemotherapy. Educ Thérapeutique Patient -Ther Patient Educ, pp.101-107, 2010. ,
Adhésion thérapeutique aux traitements oncologiques oraux et prise en charge interdisciplinaire, Rev Med Suisse La revue du praticien, vol.7, issue.55, pp.1154-1160, 2005. ,
La décision thérapeutique personnalisée. Observance médicamenteuse, La revue du praticien, vol.55, 2005. ,
Medication Compliance and Persistence: Terminology and Definitions, Value in Health, vol.11, issue.1, pp.44-51, 2008. ,
DOI : 10.1111/j.1524-4733.2007.00213.x
URL : http://doi.org/10.1111/j.1524-4733.2007.00213.x
Penser autrement l???observance m??dicamenteuse??: d???une posture injonctive ?? une alliance th??rapeutique entre le patient et le soignant ??? Concepts et d??terminants, Annales Pharmaceutiques Fran??aises, vol.70, issue.1, pp.15-25, 2012. ,
DOI : 10.1016/j.pharma.2011.10.003
Compliance, observance ou adhésion thérapeutique : de quoi parlons-nous ? Revue des maladies respiratoires, pp.31-34, 2005. ,
DOI : 10.1016/s0761-8425(05)85433-6
Comment ??valuer l???adh??sion m??dicamenteuse??? Le point sur les m??thodes, Annales Pharmaceutiques Fran??aises, vol.71, issue.2, pp.135-141, 2013. ,
DOI : 10.1016/j.pharma.2012.10.001
Patients' preference for administration of endocrine treatments by injection or tablets: results from a study of women with breast cancer, Annals of Oncology, vol.17, issue.2, pp.205-210, 2006. ,
DOI : 10.1093/annonc/mdj044
Adherence to Long-term Therapies: Evidence for Action, World Health, 2003. ,
Methods for Integrating Medication Compliance and Persistence in Pharmacoeconomic Evaluations, Value in Health, vol.10, issue.6, pp.498-509, 2007. ,
DOI : 10.1111/j.1524-4733.2007.00205.x
Making communication research matter: What do patients notice, what do patients want, and what do patients need?, Patient Education and Counseling, vol.60, issue.3, pp.272-278, 2006. ,
DOI : 10.1016/j.pec.2005.11.003
Learning needs of congestive heart failure patients, Prog Cardiovasc Nurs, vol.13, issue.2, pp.11-16, 1998. ,
Educational needs of inpatients with severe & persistent mental illness: a partial replication, J Psychosoc Nurs Ment Health Serv. mai, vol.44, issue.5, pp.38-43, 2006. ,
des études, de l'évaluation et des statistiques La vie deux ans après le diagnostic de cancer, Collection Etudes et statistiques, 2008. ,
Relating information needs to the cancer experience: 1. Information as a key coping strategy, European Journal of Cancer Care, vol.53, issue.4, pp.238-244, 1999. ,
DOI : 10.1046/j.1365-2648.1993.18071125.x
Quelles attentes des patients souffrant de cancers en hôpital de jour en termes d'information sur leur traitement ? Le Pharmacien Hospitalier et Clinicien, pp.183-190, 2010. ,
L'entretien -L'enquête et ses méthodes, Collection, vol.128, issue.19, 2005. ,
Méthodologie du recueil d'informations fondements des méthodes d'observation, de questionnaire, d'interview et d'étude de documents, 2009. ,
Les Techniques d'enquête : Méthode et exercices corrigés, 1998. ,
Health Psychology. McGraw-Hill International, 2012. ,
Constructing Grounded Theory: A Practical Guide Through Qualitative Analysis, 2006. ,
Enhancing Patient Adherence to Improve Outcomes With Oral Chemotherapy, US Pharm, vol.32, issue.10, pp.1-8, 2007. ,
Capecitabine nonadherence: exploration of magnitude, nature and contributing factors, J Oncol Pharm Pr Off Publ Int Soc Oncol Pharm Pr. sept, vol.18, issue.3, pp.333-342, 2012. ,
Adherence and Persistence With Oral Adjuvant Chemotherapy in Older Women With Early-Stage Breast Cancer in CALGB 49907: Adherence Companion Study 60104, Journal of Clinical Oncology, vol.28, issue.14, pp.2418-2422, 2010. ,
DOI : 10.1200/JCO.2009.26.4671
Patient noncompliance with self-administered chemotherapy, Cancer, vol.37, issue.1, pp.17-22, 1990. ,
DOI : 10.1002/1097-0142(19900101)65:1<17::AID-CNCR2820650106>3.0.CO;2-I
Nonadherence to imatinib treatment in patients with gastrointestinal stromal tumors: the ADAGIO study, Anticancer Res. avr, vol.31, issue.4, pp.1407-1409, 2011. ,
Prescription compliance and persistency in chronic myelogenous leukemia (CML) and gastrointestinal stromal tumor (GIST) patients (pts) on imatinib (IM), ASCO Annual Meeting Proceedings (Post-Meeting Edition, pp.2418-6119, 2006. ,
A review on adherence management in patients on oral cancer therapies, European Journal of Oncology Nursing, vol.16, issue.4 ,
DOI : 10.1016/j.ejon.2011.10.002
Adherence, compliance and persistence to oral antineoplastic therapy: a review focused on chemotherapeutic and biologic agents, Expert Opinion on Drug Safety, vol.10, issue.4, pp.49-59, 2012. ,
DOI : 10.1200/JOP.2010.000076
Évaluation de l'observance des thérapeutiques orales en oncologie : résultats d'une étude pilote, J Pharm Clin. 1 juin, vol.30, issue.2, pp.83-93, 2011. ,
What affects patient adherence to oral chemotherapy? ONS Connect, avr, vol.27, issue.4, p.24, 2012. ,
Patient adherence and persistence with oral anticancer treatment, CA: A Cancer Journal for Clinicians, vol.59, issue.1, pp.56-66, 2009. ,
DOI : 10.3322/caac.20004
Nonadherence in Patients With Breast Cancer Receiving Oral Therapies, Clinical Journal of Oncology Nursing, vol.14, issue.1, pp.41-47, 2010. ,
DOI : 10.1188/10.CJON.41-47
S??curisation de l???emploi des chimioth??rapies anticanc??reuses administrables par voie orale, Le Pharmacien Hospitalier, vol.44, issue.1, pp.36-44, 2009. ,
DOI : 10.1016/j.phhp.2008.12.002
Patient preferences for oral versus intravenous palliative chemotherapy., Journal of Clinical Oncology, vol.15, issue.1, pp.110-115, 1997. ,
DOI : 10.1200/JCO.1997.15.1.110
Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin, European Journal of Cancer, vol.38, issue.3, pp.349-358, 1990. ,
DOI : 10.1016/S0959-8049(01)00371-9
Anticancer oral therapy: Emerging related issues, Cancer Treatment Reviews, vol.36, issue.8, pp.595-605, 2010. ,
DOI : 10.1016/j.ctrv.2010.04.005
A randomised cross-over trial comparing patient preference for oral capecitabine and 5-fluorouracil/leucovorin regimens in patients with advanced colorectal cancer, Annals of Oncology, vol.17, issue.2, pp.239-245, 2006. ,
DOI : 10.1093/annonc/mdj023
Compliance, satisfaction, and quality of life of patients with colorectal cancer receiving home chemotherapy or outpatient treatment: a randomised controlled trial, BMJ, vol.322, issue.7290, p.826, 2001. ,
DOI : 10.1136/bmj.322.7290.826
Oral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process?, Eur J Cancer Care (Engl janv, vol.19, issue.11, pp.131-136, 2010. ,
Adherence with oral chemotherapy: results from a qualitative study of the behaviour and representations of patients and oncologists, European Journal of Cancer Care, vol.366, issue.4, pp.520-527, 2011. ,
DOI : 10.1111/j.1365-2354.2010.01212.x
Lapatinib Side-Effect Management, Clinical Journal of Oncology Nursing, vol.14, issue.2, pp.223-233, 2010. ,
DOI : 10.1188/10.CJON.223-233
Adherence to Therapy With Oral Antineoplastic Agents, CancerSpectrum Knowledge Environment, vol.94, issue.9, pp.652-661, 2002. ,
DOI : 10.1093/jnci/94.9.652
Perceptions and Experiences of Patients Receiving Oral Chemotherapy, Clinical Journal of Oncology Nursing, vol.14, issue.4, pp.447-453, 2010. ,
DOI : 10.1188/10.CJON.447-453
Active homebased cancer treatment, J Multidiscip Healthc, vol.5, pp.137-143, 2012. ,
Perception that Oral Anticancer Treatments are Less Efficacious: Development of a Questionnaire to Assess the Possible Prejudices of Patients with Cancer, Breast Cancer Research and Treatment, vol.23, issue.4, pp.265-272, 2005. ,
DOI : 10.1007/s10549-005-3376-y
Patient adherence to oral anticancer drugs: an emerging issue in modern oncology, Acta Clin Belg. avr, vol.66, issue.2, pp.85-96, 2011. ,
Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer, European Journal of Cancer, vol.42, issue.16, pp.2738-2743, 1990. ,
DOI : 10.1016/j.ejca.2006.06.027
Prerequisites to the administration and prevention of adverse effects of chemotherapy in colorectal cancer]. Bull Cancer (Paris), févr, vol.97, issue.2, pp.265-280, 2010. ,
Costs and utilization associated with imatinib adherence in patients with chronic myeloid leukemia or gastrointestinal stromal turmor, JCOM, vol.16, issue.5, p.215, 2009. ,
The impact of non-compliance with imatinib (IM) therapy on health care costs, ASCO Annual Meeting Proceedings (Post-Meeting Edition, pp.2418-6083, 2006. ,
Médecines complémentaires et alternatives suivies par les patients cancéreux en France, Bull Cancer, vol.94, issue.5, pp.483-488, 2007. ,
Vous avez bénéficié d'un suivi collaboratif entre le CHU de Grenoble et la plateforme de santé CPS. Afin d'améliorer l'accompagnement des patients ,
vous disposerez d'un droit d'accès, de rectification et d'opposition aux données vous concernant. Le Dr Dominique Charlety sera la personne ,
Nom : ____________________ Signature : Prénom : __________________ Signature ,